Documentation Centre

 

 

  of 516 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care. Heart. 2016;102:1957-1962 March 24, 2017 Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care. Heart. 2016;102:1957-1962 Emanuel G, Charlton J, Ashworth M, Gulliford MC, Dregan A Key Publications
Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases. Heart. 2016;102:1937-1939 March 23, 2017 Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases. Heart. 2016;102:1937-1939 González-Gay MA, González-Juanatey C Key Publications
Inflammatory obesity phenotypes, gender effects, and subclinical atherosclerosis in African Americans: The Jackson Heart Study. Arterioscler Thromb Vasc Biol. 2016;36:2431-2438 March 20, 2017 Inflammatory obesity phenotypes, gender effects, and subclinical atherosclerosis in African Americans: The Jackson Heart Study. Arterioscler Thromb Vasc Biol. 2016;36:2431-2438 Lin A, Lacy ME, Eaton C, Correa A, Wu WC Key Publications
Exercise improves insulin sensitivity in the absence of changes in cytokines. Med Sci Sports Exerc. 2016;48:2378-2386 March 10, 2017 Exercise improves insulin sensitivity in the absence of changes in cytokines. Med Sci Sports Exerc. 2016;48:2378-2386 Verheggen RJ, Poelkens F, Roerink SH, Ramakers RE, Catoire M, Hermus AR, Thijssen DH, Hopman MT Key Publications
Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration. Heart. 2016;102:1915-1921 February 28, 2017 Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration. Heart. 2016;102:1915-1921 Nsaibia MJ, Mahmut A, Mahjoub H, Dahou A, Bouchareb R, Boulanger MC, Després JP, Bossé Y, Arsenault BJ, Larose E, Pibarot P, Mathieu P Key Publications
The impact of inflammation on the obesity paradox in coronary heart disease. Int J Obes (Lond). 2016;40:1730-1735 February 24, 2017 The impact of inflammation on the obesity paradox in coronary heart disease. Int J Obes (Lond). 2016;40:1730-1735 De Schutter A, Kachur S, Lavie CJ, Boddepalli RS, Patel DA, Milani RV Key Publications
Dietary fat drives whole-body insulin resistance and promotes intestinal inflammation independent of body weight gain. Metabolism. 2016;65:1706-1719 February 16, 2017 Dietary fat drives whole-body insulin resistance and promotes intestinal inflammation independent of body weight gain. Metabolism. 2016;65:1706-1719 Jensen BA, Nielsen TS, Fritzen AM, Holm JB, Fjære E, Serup AK, Borkowski K, Risis S, Pærregaard SI, Søgaard I, Poupeau A, Poulsen M, Ma T, Sina C, Kiens B, Madsen L, Kristiansen K, Treebak JT Key Publications
Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature. 2016;539:294-298 February 16, 2017 Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature. 2016;539:294-298 Wei X, Song H, Yin L, Rizzo MG, Sidhu R, Covey DF, Ory DS, Semenkovich CF Key Publications
Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects. Eur J Clin Nutr. 2016;70:1298-1304 February 07, 2017 Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects. Eur J Clin Nutr. 2016;70:1298-1304 Mirhafez SR, Ebrahimi M, Saberi Karimian M, Avan A, Tayefi M, Heidari-Bakavoli A, Parizadeh MR, Moohebati M, Azarpazhooh MR, Esmaily H, Nematy M, Safarian M, Ferns GA, Ghayour-Mobarhan M Key Publications
Functionality of high-density lipoprotein as antiatherosclerotic therapeutic target. Arterioscler Thromb Vasc Biol. 2016;36:e87-e94 January 23, 2017 Functionality of high-density lipoprotein as antiatherosclerotic therapeutic target. Arterioscler Thromb Vasc Biol. 2016;36:e87-e94 Hoekstra M, Van Berkel TJ Key Publications

  of 516 Next page

Go to page: of